SCHEMBL1285392

SCHEMBL1285392

CCOCc1cc2ccccc2oc1=Nc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.39
AGXT P21549 1/20 0.37
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
NPC1 O15118 3/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 5/20 0.35
HPGD P15428 1/20 0.35
AGTR1 P30556 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 4/20 0.34
HTR1A P08908 2/20 0.34
HTR2B P41595 2/20 0.34
DRD2 P14416 1/20 0.34
KDM4E B2RXH2 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284938 0.90 AGXT (0.40) AGXTKMT2AMEN1NPC1MAPK1
SCHEMBL1284937 0.90 AGXT (0.40) AGXTKMT2AMEN1NPC1MAPK1
SCHEMBL1284490 0.88 MAPT (0.37) AGXTKMT2AMEN1NPC1TSHR
SCHEMBL1285468 0.88 MAPT (0.40) AGXTKMT2AMEN1TSHRALDH1A1
SCHEMBL1284491 0.88 MAPT (0.37) AGXTKMT2AMEN1NPC1TSHR
SCHEMBL1284660 0.88 MAOB (0.40) AGXTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL1285014 0.87 AKR1B10 (0.45) KMT2AMEN1NPC1MAPK1ALDH1A1
SCHEMBL1285011 0.87 AKR1B10 (0.45) KMT2AMEN1NPC1MAPK1ALDH1A1
SCHEMBL1285495 0.85 LMNA (0.37) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL1284817 0.85 KDM4E (0.36) NPC1TSHRHSD17B10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383843-B2 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-02-26 US disclosed
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND CYP3A7, CYP2A7, F7 CA12 2367/4885AGXT 1115/4885KMT2A 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.